A blockade of complement activation prevents rapid intestinal ischaemia- reperfusion injury by modulating mucosal mast cell degranulation in rats

Clinical and Experimental Immunology

Volumn 111, Issue 3, 1998, Pages 484-490

  Kimura, T ^a   Andoh, A ^a   Fujiyama, Y ^a   Saotome, T ^a   Bamba, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Anaphylatoxin; Complement; Mucosal mast cell

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; DEGRANULATION; IMMUNOHISTOCHEMISTRY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; INTESTINE PERFUSION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

ANAPHYLATOXINS; ANIMALS; CELL DEGRANULATION; CELL MEMBRANE PERMEABILITY; CHELATING AGENTS; CHROMIUM RADIOISOTOPES; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; EDETIC ACID; GUANIDINES; INTESTINAL MUCOSA; ISCHEMIA; JEJUNUM; MALE; MAST CELLS; RATS; RATS, WISTAR; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; SESQUITERPENES;

EID: 0031948554     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00518.x     Document Type: Article

References (30)

1. Boros M, Kaszaki J, Nagy S. Histamine release during intestinal ischemia-reperfusion: role of iron ions and hydrogen peroxide. Circ Shock 1991; 35:174-80.
2. Boros M, Kaszaki J, Nagy S. Oxygen free radical induced histamine release during intestinal ischemia and reperfusion. Eur Surg Res 1989; 21:297-304.
3. Kubes P, Ibbotson G, Russel J et al. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol 1990; 259:G300-G5.
4. Lehr HA, Guhlmann A, Nolte D et al. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991; 87:2036-41.
5. Smith IIIEF, Griswold DE, Egan JW et al. Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730). Eur J Pharmacol 1993; 236:477-81.
6. Ito BR, Engler RL, Del Balzo U. Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am J Physiol 1993; 264:H1346-H54.
7. Hill J, Lindsay TF, Ortiz F et al. Soluble complement receptor type I ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992; 149:1723-8.
8. Pemberton M, Anderson G, Vetvicka V et al. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol 1993; 150:5104-13.
9. Kanwar S, Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol 1994; 267:G316-G21.
10. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994; 102:803-6.
11. Bacci S, Faussone-Pellegrini MS, Mayer B et al. Distribution of mast cells in human ileocecal region. Dig Dis Sci 1995; 40:357-65.
12. Hong K, Kinoshita T, Miyazaki W et al. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J Immunol 1979; 122:2418-23.
13. Hong K, Kinoshita T, Kitajima H et al. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system. J Immunol 1981; 127:104-8.
14. Hong K, Kinoshita T, Inoue K. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid. J Immunol 1981; 127:109-14.
15. Ikari N, Sakai Y, Hitomi Y et al. New synthetic inhibitor to the alternative complement pathway. Immunol 1983; 49:685-91.
16. Fujii S, Hitomi Y. New synthetic inhibitors of Clr, Cl esterase, thrombin plasmin kallikrein and trypsin. Biochim Biophys Acta 1981; 661:342-5.
17. Hitomi Y, Fujii S. Inhibition of various immunological reactions in vivo by a new synthetic complement inhibitor. Int Archs Allergy Appl Immunol 1982; 69:262-7.
18. Ikari N, Hitomi Y, Niinobe M et al. Studies on esterolytic activity of alternative complement component factor B. Biochim Biophys Acta 1983; 742:318-23.
19. Miyagawa S, Shirakura R, Matsumiya G et al. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT-175. Transplantation 1993; 55:709-13.
20. Kido H, Fukusen N, Katunumu N. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions. Arch Biochem Biophys 1985; 239:436-43.
21. Ikai M, Itoh M, Joh T et al. Complement plays an essential role in shock following intestinal ischaemia in rats. Clin Exp Immunol 1996; 106:156-9.
22. Kanwar S, Wallace JL, Befus D et al. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266:G222-9.
23. Kubes P, Grisham MB, Barrowman JA et al. Leukocyte-induced vascular protein leakage in cat mesentery. Am J Physiol 1991; 261:H1872-9.
24. Shingu M, Nonaka S, Nishimukai H et al. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exp Immunol 1992; 90:72-78.
25. Plummer TH, Ryan TJ. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Bioph Res Commun 1981; 98:448-54.
26. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260:G355-62.
27. Jaeschke H, Bautista AP, Spolaries Z et al. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radical Res Comms 1991; 15:277-84.
28. Jaeschke H, Bautista AP, Spolarics Z et al. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukocyte Biol 1992; 52:377-82.
29. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4:3355-9.
30. Fukuoka Y, Hugli TE. Anaphylatoxin binding and degradation by rat peritoneal mast cells: mechanisms of degranulation and control. J Immunol 1990; 145:1851-8.